UPB
Upstream Bio, Inc.
5.20$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -17.6% | -7.1% | +0.0% | +7.7% | +250.0% | -12.2% | -2.3% | -6,833.3% | – | -112.0% | – | – | |
| – | +19.0% | -20.9% | +119.6% | +31.9% | +12.0% | +26.3% | -1.4% | -0.1% | -3.4% | +85.4% | -6.3% | – | |
| – | -231.8% | – | – | -88.7% | -283.8% | – | – | – | -12.7% | -246.6% | – | – | |
| – | – | – | – | – | -43.3% | -100.0% | – | +0.0% | +0.0% | -100.0% | – | – | |
| – | -142.8% | – | -942.1% | – | +2,874.3% | -609.2% | – | +277.2% | +22.3% | -28.1% | -62.8% | – | |
| – | -366.0% | – | +1,396.9% | -101.2% | – | -100.0% | – | +24.2% | +45.1% | -45.8% | +323.6% | – | |
| – | -387.2% | – | +178.8% | -189.7% | – | -186.9% | – | – | +10.1% | -116.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.